A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.
Clinical trial NCT02032888 · COMPLETED
Trial details
- NCT number
- NCT02032888
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-01
- Primary completion
- 2014-10-01
- Enrollment
- 238
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.